Global Endocrinology and Metabolism Market Growth (Status and Outlook) 2024-2030

Global Endocrinology and Metabolism Market Growth (Status and Outlook) 2024-2030

Endocrinology is the internal medicine subspecialty dedicated to the diagnosis and care of diseases and conditions related to the endocrine glands, hormones, and metabolism, the body’s physical and chemical processes to use energy or convert it for use. These diseases and conditions include type 1 and type 2 diabetes; obesity; conditions of the pituitary, thyroid, parathyroid, and adrenal glands; and metabolic disorders.

The global Endocrinology and Metabolism market size is projected to grow from US$ 93810 million in 2024 to US$ 181310 million in 2030; it is expected to grow at a CAGR of 11.6% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Endocrinology and Metabolism Industry Forecast” looks at past sales and reviews total world Endocrinology and Metabolism sales in 2022, providing a comprehensive analysis by region and market sector of projected Endocrinology and Metabolism sales for 2023 through 2029. With Endocrinology and Metabolism sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endocrinology and Metabolism industry.

This Insight Report provides a comprehensive analysis of the global Endocrinology and Metabolism landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Endocrinology and Metabolism portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endocrinology and Metabolism market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endocrinology and Metabolism and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endocrinology and Metabolism.

The rising frequency of endocrine problems, including diabetes, thyroid disorders, and hormonal imbalances, is another major factor driving the endocrinology and metabolism market. Sedentary lifestyles, bad eating habits, rising obesity rates, and an aging population all contribute to the growing global burden of endocrine illnesses. As the frequency and prevalence of these problems rise, so does the demand for diagnostic tests, medicines, and treatment procedures that address endocrine and metabolic abnormalities. This spike in demand opens up attractive prospects for market players to offer innovative products and services to meet the growing healthcare needs of people with endocrine diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Endocrinology and Metabolism market by product type, application, key players and key regions and countries.

Segmentation by Type:
Diabetes Drugs
HGH
Thyroid Hormone Disorders
Others

Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Diabetes Drugs
HGH
Thyroid Hormone Disorders
Others

Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Acerus Pharmaceuticals Corp.
Ascendis Pharma AS
Bayer AG
Beta Cell NV
Biocon Ltd.
Eli Lilly and Co.
Endo International Plc
Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Hanmi Pharm Co. Ltd.
Ipsen Pharma

Please note: The report will take approximately 2 business days to prepare and deliver.